SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-011473
Filing Date
2018-05-08
Accepted
2018-05-08 07:31:56
Documents
50
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alna-10q_20180331.htm 10-Q 1482440
2 EX-31.1 alna-ex311_7.htm EX-31.1 16697
3 EX-31.2 alna-ex312_8.htm EX-31.2 16699
4 EX-32.1 alna-ex321_6.htm EX-32.1 10177
  Complete submission text file 0001564590-18-011473.txt   4256567

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT alna-20180331.xml EX-101.INS 715706
6 XBRL TAXONOMY EXTENSION SCHEMA alna-20180331.xsd EX-101.SCH 33982
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alna-20180331_cal.xml EX-101.CAL 30477
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alna-20180331_def.xml EX-101.DEF 120972
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE alna-20180331_lab.xml EX-101.LAB 268448
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alna-20180331_pre.xml EX-101.PRE 199994
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38268 | Film No.: 18812956
SIC: 2836 Biological Products, (No Diagnostic Substances)